Patents by Inventor Claire Navarro

Claire Navarro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250186326
    Abstract: The present invention relates to a composition comprising at least one first compound of the formula (I), or a polymer of the first compound and at least one second compound of formula (I), of the following formula (II) or of the following formula (III), the second compound of formula (I) being different from the first compound of formula (I).
    Type: Application
    Filed: March 11, 2023
    Publication date: June 12, 2025
    Inventors: Sophie PERRIN, Claire NAVARRO, Héloïse LAROYE, Eric DESSAUD, Pierre CAU
  • Publication number: 20240010610
    Abstract: The present invention relates to a compound of the following formula (I): in particular for use in a method for preventing or treating a disease in an individual, more particularly for preventing or treating a disease is associated to progerin or to prelamin A.
    Type: Application
    Filed: November 24, 2021
    Publication date: January 11, 2024
    Inventors: Pierre CAU, Eric DESSAUD, Muriel AMBLARD-CAUSSIL, Pascal VERDIE, Gilles SUBRA, Alexandre DEFOUX, Claire NAVARRO, Sophie PERRIN
  • Publication number: 20170368134
    Abstract: The invention relates to a proteasome inhibitor for use for treating and/or preventing a disorder related to an accumulation of a non-degraded abnormal protein, particularly a premature ageing disorder. The invention also relates to the use of proteasome inhibitors for attenuating physiological ageing. The invention also relates to the use of proteasome inhibitors in the treatment and/or prevention of age-related disorders and their metabolic consequences. The invention also relates to the dermato logical, dermo cosmetic or cosmetic use of a proteasome inhibitor for preventing and/or attenuating skin ageing. The invention also relates to the use of proteasome inhibitors in the treatment of cancer.
    Type: Application
    Filed: January 14, 2016
    Publication date: December 28, 2017
    Inventors: Nicolas Levy, Pierre Cau, Annachiara De Sandre-Giovannoli, Karim Harhouri, Sophie Perrin, Claire Navarro, Aymeric Chartier, Martine Simonelig